Potential Harm of E-cigarette Sales on Youth Health

Regulations by 2FIRSTS.ai
Aug.29.2023
Potential Harm of E-cigarette Sales on Youth Health
E-cigarette sales have surged by 50% between 2020 and 2022, raising concerns over the growing popularity among underage users.

According to reports from foreign media, e-cigarette sales have increased by 50% between 2020 and 2022, as per the latest data from the US Centers for Disease Control and Prevention. Experts believe that one of the main reasons for this growth is the availability of flavor-based products targeting underage individuals.

 

A government survey estimates that 2.5 million young people are using e-cigarettes, and an increasing number of e-cigarette products are now containing nicotine. Health experts believe that this could be extremely detrimental to the growth and development of young people.

 

Liz Pray, of the American National Association of School Nurses, has asserted that the chemicals found in these e-cigarettes are having a detrimental impact on brain development and lung health. In fact, we may still not fully comprehend their potential long-term effects.

 

The school nurse suggests parents discuss the hazards of e-cigarettes with their children, while emphasizing the advocates' call for a wider ban on the sale of e-cigarettes and the use of e-cigarette products.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.